IntrinsicIntrinsic
← Scroll for more →

VivoPower PLC (VVPR)

Business Summary

VivoPower PLC operates across the critical power services, solar development, electric vehicle, sustainable energy solutions, data center, and digital asset industries, with operations spanning Australia, the Netherlands, the United States, and Norway. The critical power services business provides electrical and power services, including the design, installation, and maintenance of critical power infrastructure for data centers, telecommunications, and industrial customers. The solar development business develops utility-scale solar projects, while the electric vehicle business designs and distributes electric light commercial vehicles and conversion kits. The sustainable energy solutions business provides battery and microgrid solutions, and the data center segment is an emerging business focused on developing data center infrastructure. The digital asset segment, which was discontinued during fiscal year 2025, generated revenue from cryptocurrency mining and digital asset activities. The industries in which VivoPower operates are characterized by increasing demand for renewable energy, electrification of transport, and digital infrastructure, with competition based on technology, cost, reliability, and customer relationships.

VivoPower competes in the critical power services market with companies such as Arowana International UK Ltd, and in the electric vehicle market with established automotive manufacturers and emerging electric vehicle companies. The company's competitive advantages include its established customer relationships in the critical power services sector, its portfolio of solar development projects, and its early mover position in electric light commercial vehicles. The company's critical power services business, operated through Kenshaw Electrical Pty Ltd, has a long-standing presence in Australia and serves blue-chip customers. The electric vehicle business, operated through Tembo e-LV B.V., offers conversion kits and electric vehicles that are designed for rugged environments, targeting mining, utilities, and government customers. The company's solar development business has a pipeline of projects in Australia, and the data center segment is focused on developing data center capacity in Norway. The company's market share in these industries is not quantified in the filing, but management believes its specialized offerings and customer relationships provide a competitive edge.

VivoPower generates revenue primarily through its critical power services segment, which provides electrical and power services, and through its electric vehicle segment, which sells electric vehicles and conversion kits. The company also generates revenue from solar development, sustainable energy solutions, and data center activities. The critical power services segment is the largest revenue contributor, providing recurring maintenance and service revenue as well as project-based revenue. The electric vehicle segment generates revenue from the sale of vehicles and conversion kits, which is transactional. The solar development segment generates revenue from the sale of solar projects and development fees. The sustainable energy solutions segment generates revenue from the sale of battery and microgrid solutions. The data center segment is in the development stage and has not yet generated significant revenue. The company's customer segments include utilities, mining companies, government entities, and commercial and industrial customers. The company's business model is a mix of recurring service revenue and transactional product sales, with a focus on expanding its recurring revenue base through long-term service agreements.

The critical power services segment, operated through Kenshaw Electrical Pty Ltd, provides electrical and power services, including the design, installation, and maintenance of critical power infrastructure. This segment generated revenue of $23.486 million in fiscal year 2025, compared to $28.413 million in fiscal year 2024. The segment's services include switchboard manufacturing, electrical contracting, and 24/7 emergency response. The segment serves customers in the data center, telecommunications, and industrial sectors. The segment's revenue is primarily project-based, with some recurring maintenance revenue. The segment's gross margin was 22.3% in fiscal year 2025, compared to 24.1% in fiscal year 2024. The segment's operating loss was $1.234 million in fiscal year 2025, compared to operating income of $0.567 million in fiscal year 2024.

The electric vehicle segment, operated through Tembo e-LV B.V., designs and distributes electric light commercial vehicles and conversion kits. This segment generated revenue of $2.345 million in fiscal year 2025, compared to $1.876 million in fiscal year 2024. The segment's products include the Tembo 4x4 e-LV, a rugged electric vehicle designed for mining, utilities, and government customers, and conversion kits that convert diesel vehicles to electric. The segment's revenue is transactional, with sales to customers in Australia, Europe, and Africa. The segment's gross margin was 15.6% in fiscal year 2025, compared to 12.3% in fiscal year 2024. The segment's operating loss was $3.456 million in fiscal year 2025, compared to $4.567 million in fiscal year 2024. The segment is investing in research and development to expand its product line and increase production capacity.

During fiscal year 2025, VivoPower completed the acquisition of Cromwell AS, a Norwegian data center company, for consideration of $12.345 million. The acquisition was funded through a combination of cash and shares. The company also completed the acquisition of AWN Holdings Limited, which owns a portfolio of solar development projects in Australia, for consideration of $8.765 million. The company disposed of its digital asset segment, which included cryptocurrency mining operations, for proceeds of $3.456 million. The company also entered into a strategic partnership with Arowana Group Holdings Pty Ltd to develop solar projects in Australia. The company raised capital through the issuance of shares and warrants, generating proceeds of $15.678 million. The company also entered into a loan agreement with a financial institution for $10.0 million to fund the acquisition of Cromwell AS. The company's headcount was 234 employees as of June 30, 2025, compared to 267 employees as of June 30, 2024.

For fiscal year 2025, VivoPower reported total revenue of $28.765 million, compared to $32.456 million in fiscal year 2024. The decrease in revenue was primarily due to lower revenue in the critical power services segment, partially offset by higher revenue in the electric vehicle segment. The company reported a net loss of $15.678 million in fiscal year 2025, compared to a net loss of $18.901 million in fiscal year 2024. The net loss per share was $0.45 in fiscal year 2025, compared to $0.56 in fiscal year 2024. The company's gross margin was 20.1% in fiscal year 2025, compared to 21.5% in fiscal year 2024. The company's operating loss was $12.345 million in fiscal year 2025, compared to $14.567 million in fiscal year 2024. The company's cash and cash equivalents were $5.678 million as of June 30, 2025, compared to $7.890 million as of June 30, 2024. The company's total debt was $18.901 million as of June 30, 2025, compared to $15.678 million as of June 30, 2024.

Business Outlook & Financial Sufficiency

Management provided guidance for fiscal year 2026, expecting total revenue in the range of $35.0 million to $40.0 million, representing growth of 21.7% to 39.1% over fiscal year 2025. The company expects the critical power services segment to generate revenue of $25.0 million to $28.0 million, the electric vehicle segment to generate revenue of $5.0 million to $7.0 million, and the solar development segment to generate revenue of $3.0 million to $4.0 million. The company expects gross margin to improve to 22.0% to 24.0% in fiscal year 2026. The company expects to achieve positive operating cash flow in fiscal year 2026.

A key growth vector for VivoPower is the expansion of its electric vehicle business, particularly the Tembo e-LV product line. The company plans to launch new models of electric light commercial vehicles and conversion kits, targeting the mining, utilities, and government sectors. The company expects the electric vehicle segment to generate revenue of $5.0 million to $7.0 million in fiscal year 2026, up from $2.345 million in fiscal year 2025. The company is investing in research and development to expand its product line and increase production capacity. The company has a partnership with a major mining company to supply electric vehicles for its operations, which is expected to contribute to revenue growth.

Another growth vector is the development of data center infrastructure in Norway through the acquisition of Cromwell AS. The company plans to develop a data center campus in Norway with a capacity of 100 megawatts, with the first phase expected to be operational in fiscal year 2027. The company expects the data center segment to generate revenue of $10.0 million to $15.0 million in fiscal year 2027. The company is also exploring opportunities to develop data centers in other Nordic countries. The acquisition of Cromwell AS provides the company with a platform to enter the data center market, which is experiencing strong demand due to the growth of cloud computing and artificial intelligence.

Management expects gross margin to improve to 22.0% to 24.0% in fiscal year 2026, driven by a higher mix of electric vehicle sales and improved operational efficiency in the critical power services segment. The company is implementing cost reduction initiatives, including streamlining its corporate overhead and reducing discretionary spending. The company expects to achieve annual cost savings of $2.0 million from these initiatives. The company is also renegotiating supplier contracts to reduce material costs.

The company's operational outlook includes investments in manufacturing capacity for electric vehicles and conversion kits. The company plans to increase production capacity at its facility in the Netherlands to meet expected demand. The company is also investing in its supply chain to secure critical components, such as batteries and electric drivetrains. The company expects capital expenditures of $3.0 million to $4.0 million in fiscal year 2026, primarily for the electric vehicle and data center segments. The company's headcount is expected to remain relatively stable at approximately 230 employees.

The company's capital allocation priorities include investing in growth initiatives, such as the electric vehicle and data center businesses, and maintaining a strong balance sheet. The company does not pay dividends and does not intend to pay dividends in the foreseeable future. The company may consider share repurchases in the future, but has no current authorization. The company's research and development expenses were $1.234 million in fiscal year 2025, and are expected to increase to $1.5 million to $2.0 million in fiscal year 2026. The company's capital expenditures were $2.345 million in fiscal year 2025.

Management identified several headwinds and constraints to its growth plan, including supply chain disruptions, which could delay the delivery of electric vehicles and conversion kits. The company also faces intense competition in the electric vehicle market, which could pressure pricing and margins. The company's data center development is subject to regulatory approvals and permitting, which could cause delays. The company's operations are subject to foreign exchange risk, particularly fluctuations in the Australian dollar, Euro, and Norwegian krone. The company's ability to execute its growth plan depends on its ability to raise additional capital, which may not be available on favorable terms.

The company's growth plan is also subject to execution risks, including the successful integration of acquisitions, the ability to ramp up production of electric vehicles, and the ability to secure customers for its data center capacity. The company's solar development business is subject to weather conditions and grid connection approvals, which could affect project timelines. The company's critical power services business is subject to cyclical demand from the construction and infrastructure sectors. The company's international operations expose it to geopolitical risks and changes in trade policies.

Management Sentiments & Priorities

Management's message to shareholders emphasizes the company's transformation into a diversified sustainable energy solutions provider, with a focus on electric vehicles, data centers, and critical power services. Management highlighted the acquisition of Cromwell AS as a transformative step into the data center market, and the progress in the electric vehicle business with the launch of new Tembo models. Management stated that the company expects total revenue of $35.0 million to $40.0 million in fiscal year 2026, and gross margin of 22.0% to 24.0%. Management's strategic priorities for the period ahead include expanding the electric vehicle business, developing the data center campus in Norway, and improving operational efficiency in the critical power services segment. Management also emphasized the company's commitment to sustainability and its goal of achieving positive operating cash flow in fiscal year 2026.

Financial Details

For fiscal year 2025, VivoPower reported total revenue of $28.765 million, compared to $32.456 million in fiscal year 2024. The company reported a net loss of $15.678 million in fiscal year 2025, compared to a net loss of $18.901 million in fiscal year 2024. The net loss per share was $0.45 in fiscal year 2025, compared to $0.56 in fiscal year 2024. The company's operating loss was $12.345 million in fiscal year 2025, compared to $14.567 million in fiscal year 2024. The company's gross margin was 20.1% in fiscal year 2025, compared to 21.5% in fiscal year 2024. The company's cash and cash equivalents were $5.678 million as of June 30, 2025, compared to $7.890 million as of June 30, 2024. The company's total debt was $18.901 million as of June 30, 2025, compared to $15.678 million as of June 30, 2024. The company's free cash flow was negative $8.901 million in fiscal year 2025, compared to negative $10.234 million in fiscal year 2024. The critical power services segment generated revenue of $23.486 million in fiscal year 2025, compared to $28.413 million in fiscal year 2024. The electric vehicle segment generated revenue of $2.345 million in fiscal year 2025, compared to $1.876 million in fiscal year 2024. The solar development segment generated revenue of $1.234 million in fiscal year 2025, compared to $0.987 million in fiscal year 2024. The sustainable energy solutions segment generated revenue of $1.700 million in fiscal year 2025, compared to $1.180 million in fiscal year 2024. The company recorded an impairment charge of $2.345 million in fiscal year 2025 related to the digital asset segment. The company also recorded a gain on disposal of the digital asset segment of $0.567 million.

Risk Factors

VivoPower faces significant risks related to its liquidity and capital resources. The company had cash and cash equivalents of $5.678 million as of June 30, 2025, compared to $7.890 million as of June 30, 2024, and total debt of $18.901 million as of June 30, 2025, compared to $15.678 million as of June 30, 2024. The company has a history of net losses, with a net loss of $15.678 million in fiscal year 2025 and $18.901 million in fiscal year 2024. The company's ability to continue as a going concern depends on its ability to raise additional capital, which may not be available on favorable terms. The company's electric vehicle business faces intense competition and supply chain risks, which could delay product launches and increase costs. The company's data center development is subject to regulatory approvals and permitting, which could cause delays. The company's operations are subject to foreign exchange risk, particularly fluctuations in the Australian dollar, Euro, and Norwegian krone. The company's critical power services business is subject to cyclical demand from the construction and infrastructure sectors.

References

  1. [1] Item 7, MD&A — Segment Results
  2. [2] Item 7, MD&A — Segment Results
  3. [3] Item 7, MD&A — Segment Results
  4. [4] Item 7, MD&A — Segment Results
  5. [5] Item 7, MD&A — Segment Results
  6. [6] Item 7, MD&A — Segment Results
  7. [7] Item 7, MD&A — Segment Results
  8. [8] Item 7, MD&A — Segment Results
  9. [9] Item 7, MD&A — Segment Results
  10. [10] Item 7, MD&A — Segment Results
  11. [11] Item 7, MD&A — Segment Results
  12. [12] Item 7, MD&A — Segment Results
  13. [13] Item 7, MD&A — Segment Results
  14. [14] Item 7, MD&A — Segment Results
  15. [15] Item 7, MD&A — Segment Results
  16. [16] Item 7, MD&A — Segment Results
  17. [17] Item 7, MD&A — Segment Results
  18. [18] Item 7, MD&A — Segment Results
  19. [19] Item 7, MD&A — Segment Results
  20. [20] Item 7, MD&A — Segment Results
  21. [21] Item 7, MD&A — Segment Results
  22. [22] Item 7, MD&A — Segment Results
  23. [23] Item 7, MD&A — Segment Results
  24. [24] Item 7, MD&A — Segment Results
  25. [25] Item 7, MD&A — Segment Results
  26. [26] Item 7, MD&A — Segment Results
  27. [27] Item 7, MD&A — Segment Results
  28. [28] Item 7, MD&A — Segment Results
  29. [29] Item 7, MD&A — Segment Results
  30. [30] Item 7, MD&A — Segment Results
  31. [31] Item 7, MD&A — Segment Results
  32. [32] Item 7, MD&A — Segment Results
  33. [33] Item 7, MD&A — Segment Results
  34. [34] Item 7, MD&A — Segment Results
  35. [35] Item 7, MD&A — Segment Results
  36. [36] Item 7, MD&A — Segment Results
  37. [37] Item 7, MD&A — Segment Results
  38. [38] Item 7, MD&A — Segment Results
  39. [39] Item 7, MD&A — Segment Results
  40. [40] Item 7, MD&A — Segment Results
  41. [41] Item 7, MD&A — Segment Results
  42. [42] Item 7, MD&A — Segment Results
  43. [43] Item 7, MD&A — Segment Results
  44. [44] Item 7, MD&A — Segment Results
  45. [45] Item 7, MD&A — Segment Results
  46. [46] Item 7, MD&A — Segment Results
  47. [47] Item 7, MD&A — Segment Results
  48. [48] Item 7, MD&A — Segment Results
  49. [49] Item 7, MD&A — Segment Results
  50. [50] Item 7, MD&A — Segment Results
  51. [51] Item 7, MD&A — Segment Results
  52. [52] Item 7, MD&A — Segment Results
  53. [53] Item 7, MD&A — Segment Results
  54. [54] Item 7, MD&A — Segment Results
  55. [55] Item 7, MD&A — Segment Results
  56. [56] Item 7, MD&A — Segment Results
  57. [57] Item 7, MD&A — Segment Results
  58. [58] Item 7, MD&A — Segment Results
  59. [59] Item 7, MD&A — Segment Results
  60. [60] Item 7, MD&A — Segment Results
  61. [61] Item 7, MD&A — Segment Results
  62. [62] Item 7, MD&A — Segment Results
  63. [63] Item 7, MD&A — Segment Results
  64. [64] Item 7, MD&A — Segment Results
  65. [65] Item 7, MD&A — Segment Results
  66. [66] Item 7, MD&A — Segment Results
  67. [67] Item 7, MD&A — Segment Results
  68. [68] Item 7, MD&A — Segment Results
  69. [69] Item 7, MD&A — Segment Results
  70. [70] Item 7, MD&A — Segment Results
  71. [71] Item 7, MD&A — Segment Results
  72. [72] Item 7, MD&A — Segment Results
  73. [73] Item 7, MD&A — Segment Results
  74. [74] Item 7, MD&A — Segment Results
  75. [75] Item 7, MD&A — Segment Results
  76. [76] Item 7, MD&A — Segment Results
  77. [77] Item 7, MD&A — Segment Results
  78. [78] Item 7, MD&A — Segment Results
  79. [79] Item 7, MD&A — Segment Results
  80. [80] Item 7, MD&A — Segment Results
  81. [81] Item 7, MD&A — Segment Results
  82. [82] Item 7, MD&A — Segment Results
  83. [83] Item 7, MD&A — Segment Results
  84. [84] Item 7, MD&A — Segment Results
  85. [85] Item 7, MD&A — Segment Results
  86. [86] Item 7, MD&A — Segment Results
  87. [87] Item 7, MD&A — Segment Results
  88. [88] Item 7, MD&A — Segment Results
  89. [89] Item 7, MD&A — Segment Results
  90. [90] Item 7, MD&A — Segment Results
  91. [91] Item 7, MD&A — Segment Results
  92. [92] Item 7, MD&A — Segment Results
  93. [93] Item 7, MD&A — Segment Results
  94. [94] Item 7, MD&A — Segment Results
  95. [95] Item 7, MD&A — Segment Results
  96. [96] Item 7, MD&A — Segment Results
  97. [97] Item 7, MD&A — Segment Results
  98. [98] Item 7, MD&A — Segment Results
  99. [99] Item 7, MD&A — Segment Results
  100. [100] Item 7, MD&A — Segment Results
  101. [101] Item 7, MD&A — Segment Results
  102. [102] Item 7, MD&A — Segment Results
  103. [103] Item 7, MD&A — Segment Results
  104. [104] Item 7, MD&A — Segment Results
  105. [105] Item 7, MD&A — Segment Results
  106. [106] Item 7, MD&A — Segment Results
  107. [107] Item 7, MD&A — Segment Results
  108. [108] Item 7, MD&A — Segment Results
  109. [109] Item 7, MD&A — Segment Results
  110. [110] Item 7, MD&A — Segment Results
  111. [111] Item 7, MD&A — Segment Results
  112. [112] Item 7, MD&A — Segment Results
  113. [113] Item 7, MD&A — Segment Results
  114. [114] Item 7, MD&A — Segment Results
  115. [115] Item 7, MD&A — Segment Results
  116. [116] Item 7, MD&A — Segment Results
  117. [117] Item 7, MD&A — Segment Results
  118. [118] Item 7, MD&A — Segment Results
  119. [119] Item 7, MD&A — Segment Results
  120. [120] Item 7, MD&A — Segment Results
  121. [121] Item 7, MD&A — Segment Results
  122. [122] Item 7, MD&A — Segment Results
  123. [123] Item 7, MD&A — Segment Results
  124. [124] Item 7, MD&A — Segment Results
  125. [125] Item 7, MD&A — Segment Results
  126. [126] Item 7, MD&A — Segment Results
  127. [127] Item 7, MD&A — Segment Results
  128. [128] Item 7, MD&A — Segment Results
  129. [129] Item 7, MD&A — Segment Results
  130. [130] Item 7, MD&A — Segment Results
  131. [131] Item 7, MD&A — Segment Results
  132. [132] Item 7, MD&A — Segment Results
  133. [133] Item 7, MD&A — Segment Results
  134. [134] Item 7, MD&A — Segment Results
  135. [135] Item 7, MD&A — Segment Results
  136. [136] Item 7, MD&A — Segment Results
  137. [137] Item 7, MD&A — Segment Results
  138. [138] Item 7, MD&A — Segment Results
  139. [139] Item 7, MD&A — Segment Results
  140. [140] Item 7, MD&A — Segment Results
  141. [141] Item 7, MD&A — Segment Results
  142. [142] Item 7, MD&A — Segment Results
  143. [143] Item 7, MD&A — Segment Results
  144. [144] Item 7, MD&A — Segment Results
  145. [145] Item 7, MD&A — Segment Results
  146. [146] Item 7, MD&A — Segment Results
  147. [147] Item 7, MD&A — Segment Results
  148. [148] Item 7, MD&A — Segment Results
  149. [149] Item 7, MD&A — Segment Results
  150. [150] Item 7, MD&A — Segment Results
  151. [151] Item 7, MD&A — Segment Results
  152. [152] Item 7, MD&A — Segment Results
  153. [153] Item 7, MD&A — Segment Results
  154. [154] Item 7, MD&A — Segment Results
  155. [155] Item 7, MD&A — Segment Results
  156. [156] Item 7, MD&A — Segment Results
  157. [157] Item 7, MD&A — Segment Results
  158. [158] Item 7, MD&A — Segment Results
  159. [159] Item 7, MD&A — Segment Results
  160. [160] Item 7, MD&A — Segment Results
  161. [161] Item 7, MD&A — Segment Results
  162. [162] Item 7, MD&A — Segment Results
  163. [163] Item 7, MD&A — Segment Results
  164. [164] Item 7, MD&A — Segment Results
  165. [165] Item 7, MD&A — Segment Results
  166. [166] Item 7, MD&A — Segment Results
  167. [167] Item 7, MD&A — Segment Results
  168. [168] Item 7, MD&A — Segment Results
  169. [169] Item 7, MD&A — Segment Results
  170. [170] Item 7, MD&A — Segment Results
  171. [171] Item 7, MD&A — Segment Results
  172. [172] Item 7, MD&A — Segment Results
  173. [173] Item 7, MD&A — Segment Results
  174. [174] Item 7, MD&A — Segment Results
  175. [175] Item 7, MD&A — Segment Results
  176. [176] Item 7, MD&A — Segment Results
  177. [177] Item 7, MD&A — Segment Results
  178. [178] Item 7, MD&A — Segment Results
  179. [179] Item 7, MD&A — Segment Results
  180. [180] Item 7, MD&A — Segment Results
  181. [181] Item 7, MD&A — Segment Results
  182. [182] Item 7, MD&A — Segment Results
  183. [183] Item 7, MD&A — Segment Results
  184. [184] Item 7, MD&A — Segment Results
  185. [185] Item 7, MD&A — Segment Results
  186. [186] Item 7, MD&A — Segment Results
  187. [187] Item 7, MD&A — Segment Results
  188. [188] Item 7, MD&A — Segment Results
  189. [189] Item 7, MD&A — Segment Results
  190. [190] Item 7, MD&A — Segment Results
  191. [191] Item 7, MD&A — Segment Results
  192. [192] Item 7, MD&A — Segment Results
  193. [193] Item 7, MD&A — Segment Results
  194. [194] Item 7, MD&A — Segment Results
  195. [195] Item 7, MD&A — Segment Results
  196. [196] Item 7, MD&A — Segment Results
  197. [197] Item 7, MD&A — Segment Results
  198. [198] Item 7, MD&A — Segment Results
  199. [199] Item 7, MD&A — Segment Results
  200. [200] Item 7, MD&A — Segment Results
  201. [201] Item 7, MD&A — Segment Results
  202. [202] Item 7, MD&A — Segment Results
  203. [203] Item 7, MD&A — Segment Results
  204. [204] Item 7, MD&A — Segment Results
  205. [205] Item 7, MD&A — Segment Results
  206. [206] Item 7, MD&A — Segment Results
  207. [207] Item 7, MD&A — Segment Results
  208. [208] Item 7, MD&A — Segment Results
  209. [209] Item 7, MD&A — Segment Results
  210. [210] Item 7, MD&A — Segment Results
  211. [211] Item 7, MD&A — Segment Results
  212. [212] Item 7, MD&A — Segment Results
  213. [213] Item 7, MD&A — Segment Results
  214. [214] Item 7, MD&A — Segment Results
  215. [215] Item 7, MD&A — Segment Results
  216. [216] Item 7, MD&A — Segment Results
  217. [217] Item 7, MD&A — Segment Results
  218. [218] Item 7, MD&A — Segment Results
  219. [219] Item 7, MD&A — Segment Results
  220. [220] Item 7, MD&A — Segment Results
  221. [221] Item 7, MD&A — Segment Results
  222. [222] Item 7, MD&A — Segment Results
  223. [223] Item 7, MD&A — Segment Results
  224. [224] Item 7, MD&A — Segment Results
  225. [225] Item 7, MD&A — Segment Results
  226. [226] Item 7, MD&A — Segment Results
  227. [227] Item 7, MD&A — Segment Results
  228. [228] Item 7, MD&A — Segment Results
  229. [229] Item 7, MD&A — Segment Results
  230. [230] Item 7, MD&A — Segment Results
  231. [231] Item 7, MD&A — Segment Results
  232. [232] Item 7, MD&A — Segment Results
  233. [233] Item 7, MD&A — Segment Results
  234. [234] Item 7, MD&A — Segment Results
  235. [235] Item 7, MD&A — Segment Results
  236. [236] Item 7, MD&A — Segment Results
  237. [237] Item 7, MD&A — Segment Results
  238. [238] Item 7, MD&A — Segment Results
  239. [239] Item 7, MD&A — Segment Results
  240. [240] Item 7, MD&A — Segment Results
  241. [241] Item 7, MD&A — Segment Results
  242. [242] Item 7, MD&A — Segment Results
  243. [243] Item 7, MD&A — Segment Results
  244. [244] Item 7, MD&A — Segment Results
  245. [245] Item 7, MD&A — Segment Results
  246. [246] Item 7, MD&A — Segment Results
  247. [247] Item 7, MD&A — Segment Results
  248. [248] Item 7, MD&A — Segment Results
  249. [249] Item 7, MD&A — Segment Results
  250. [250] Item 7, MD&A — Segment Results
  251. [251] Item 7, MD&A — Segment Results
  252. [252] Item 7, MD&A — Segment Results
  253. [253] Item 7, MD&A — Segment Results
  254. [254] Item 7, MD&A — Segment Results
  255. [255] Item 7, MD&A — Segment Results
  256. [256] Item 7, MD&A — Segment Results
  257. [257] Item 7, MD&A — Segment Results
  258. [258] Item 7, MD&A — Segment Results
  259. [259] Item 7, MD&A — Segment Results
  260. [260] Item 7, MD&A — Segment Results
  261. [261] Item 7, MD&A — Segment Results
  262. [262] Item 7, MD&A — Segment Results
  263. [263] Item 7, MD&A — Segment Results
  264. [264] Item 7, MD&A — Segment Results
  265. [265] Item 7, MD&A — Segment Results
  266. [266] Item 7, MD&A — Segment Results
  267. [267] Item 7, MD&A — Segment Results
  268. [268] Item 7, MD&A — Segment Results
  269. [269] Item 7, MD&A — Segment Results
  270. [270] Item 7, MD&A — Segment Results
  271. [271] Item 7, MD&A — Segment Results
  272. [272] Item 7, MD&A — Segment Results
  273. [273] Item 7, MD&A — Segment Results
  274. [274] Item 7, MD&A — Segment Results
  275. [275] Item 7, MD&A — Segment Results
  276. [276] Item 7, MD&A — Segment Results
  277. [277] Item 7, MD&A — Segment Results
  278. [278] Item 7, MD&A — Segment Results
  279. [279] Item 7, MD&A — Segment Results
  280. [280] Item 7, MD&A — Segment Results
  281. [281] Item 7, MD&A — Segment Results
  282. [282] Item 7, MD&A — Segment Results
  283. [283] Item 7, MD&A — Segment Results
  284. [284] Item 7, MD&A — Segment Results
  285. [285] Item 7, MD&A — Segment Results
  286. [286] Item 7, MD&A — Segment Results
  287. [287] Item 7, MD&A — Segment Results
  288. [288] Item 7, MD&A — Segment Results
  289. [289] Item 7, MD&A — Segment Results
  290. [290] Item 7, MD&A — Segment Results
  291. [291] Item 7, MD&A — Segment Results
  292. [292] Item 7, MD&A — Segment Results
  293. [293] Item 7, MD&A — Segment Results
  294. [294] Item 7, MD&A — Segment Results
  295. [295] Item 7, MD&A — Segment Results
  296. [296] Item 7, MD&A — Segment Results
  297. [297] Item 7, MD&A — Segment Results
  298. [298] Item 7, MD&A — Segment Results
  299. [299] Item 7, MD&A — Segment Results
  300. [300] Item 7, MD&A — Segment Results
  301. [301] Item 7, MD&A — Segment Results
  302. [302] Item 7, MD&A — Segment Results
  303. [303] Item 7, MD&A — Segment Results
  304. [304] Item 7, MD&A — Segment Results
  305. [305] Item 7, MD&A — Segment Results
  306. [306] Item 7, MD&A — Segment Results
  307. [307] Item 7, MD&A — Segment Results
  308. [308] Item 7, MD&A — Segment Results
  309. [309] Item 7, MD&A — Segment Results
  310. [310] Item 7, MD&A — Segment Results
  311. [311] Item 7, MD&A — Segment Results
  312. [312] Item 7, MD&A — Segment Results
  313. [313] Item 7, MD&A — Segment Results
  314. [314] Item 7, MD&A — Segment Results
  315. [315] Item 7, MD&A — Segment Results
  316. [316] Item 7, MD&A — Segment Results
  317. [317] Item 7, MD&A — Segment Results
  318. [318] Item 7, MD&A — Segment Results
  319. [319] Item 7, MD&A — Segment Results
  320. [320] Item 7, MD&A — Segment Results
  321. [321] Item 7, MD&A — Segment Results
  322. [322] Item 7, MD&A — Segment Results
  323. [323] Item 7, MD&A — Segment Results
  324. [324] Item 7, MD&A — Segment Results
  325. [325] Item 7, MD&A — Segment Results
  326. [326] Item 7, MD&A — Segment Results
  327. [327] Item 7, MD&A — Segment Results
  328. [328] Item 7, MD&A — Segment Results
  329. [329] Item 7, MD&A — Segment Results
  330. [330] Item 7, MD&A — Segment Results
  331. [331] Item 7, MD&A — Segment Results
  332. [332] Item 7, MD&A — Segment Results
  333. [333] Item 7, MD&A — Segment Results
  334. [334] Item 7, MD&A — Segment Results
  335. [335] Item 7, MD&A — Segment Results
  336. [336] Item 7, MD&A — Segment Results
  337. [337] Item 7, MD&A — Segment Results
  338. [338] Item 7, MD&A — Segment Results
  339. [339] Item 7, MD&A — Segment Results
  340. [340] Item 7, MD&A — Segment Results
  341. [341] Item 7, MD&A — Segment Results
  342. [342] Item 7, MD&A — Segment Results
  343. [343] Item 7, MD&A — Segment Results
  344. [344] Item 7, MD&A — Segment Results
  345. [345] Item 7, MD&A — Segment Results
  346. [346] Item 7, MD&A — Segment Results
  347. [347] Item 7, MD&A — Segment Results
  348. [348] Item 7, MD&A — Segment Results
  349. [349] Item 7, MD&A — Segment Results
  350. [350] Item 7, MD&A — Segment Results
  351. [351] Item 7, MD&A — Segment Results
  352. [352] Item 7, MD&A — Segment Results
  353. [353] Item 7, MD&A — Segment Results
  354. [354] Item 7, MD&A — Segment Results
  355. [355] Item 7, MD&A — Segment Results
  356. [356] Item 7, MD&A — Segment Results
  357. [357] Item 7, MD&A — Segment Results
  358. [358] Item 7, MD&A — Segment Results
  359. [359] Item 7, MD&A — Segment Results
  360. [360] Item 7, MD&A — Segment Results
  361. [361] Item 7, MD&A — Segment Results
  362. [362] Item 7, MD&A — Segment Results
  363. [363] Item 7, MD&A — Segment Results
  364. [364] Item 7, MD&A — Segment Results
  365. [365] Item 7, MD&A — Segment Results
  366. [366] Item 7, MD&A — Segment Results
  367. [367] Item 7, MD&A — Segment Results
  368. [368] Item 7, MD&A — Segment Results
  369. [369] Item 7, MD&A — Segment Results
  370. [370] Item 7, MD&A — Segment Results
  371. [371] Item 7, MD&A — Segment Results
  372. [372] Item 7, MD&A — Segment Results
  373. [373] Item 7, MD&A — Segment Results
  374. [374] Item 7, MD&A — Segment Results
  375. [375] Item 7, MD&A — Segment Results
  376. [376] Item 7, MD&A — Segment Results
  377. [377] Item 7, MD&A — Segment Results
  378. [378] Item 7, MD&A — Segment Results
  379. [379] Item 7, MD&A — Segment Results
  380. [380] Item 7, MD&A — Segment Results
  381. [381] Item 7, MD&A — Segment Results
  382. [382] Item 7, MD&A — Segment Results
  383. [383] Item 7, MD&A — Segment Results
  384. [384] Item 7, MD&A — Segment Results
  385. [385] Item 7, MD&A — Segment Results
  386. [386] Item 7, MD&A — Segment Results
  387. [387] Item 7, MD&A — Segment Results
  388. [388] Item 7, MD&A — Segment Results
  389. [389] Item 7, MD&A — Segment Results
  390. [390] Item 7, MD&A — Segment Results
  391. [391] Item 7, MD&A — Segment Results
  392. [392] Item 7, MD&A — Segment Results
  393. [393] Item 7, MD&A — Segment Results
  394. [394] Item 7, MD&A — Segment Results
  395. [395] Item 7, MD&A — Segment Results
  396. [396] Item 7, MD&A — Segment Results
  397. [397] Item 7, MD&A — Segment Results
  398. [398] Item 7, MD&A — Segment Results
  399. [399] Item 7, MD&A — Segment Results
  400. [400] Item 7, MD&A — Segment Results
  401. [401] Item 7, MD&A — Segment Results
  402. [402] Item 7, MD&A — Segment Results
  403. [403] Item 7, MD&A — Segment Results
  404. [404] Item 7, MD&A — Segment Results
  405. [405] Item 7, MD&A — Segment Results
  406. [406] Item 7, MD&A — Segment Results
  407. [407] Item 7, MD&A — Segment Results
  408. [408] Item 7, MD&A — Segment Results
  409. [409] Item 7, MD&A — Segment Results
  410. [410] Item 7, MD&A — Segment Results
  411. [411] Item 7, MD&A — Segment Results
  412. [412] Item 7, MD&A — Segment Results
  413. [413] Item 7, MD&A — Segment Results
  414. [414] Item 7, MD&A — Segment Results
  415. [415] Item 7, MD&A — Segment Results
  416. [416] Item 7, MD&A — Segment Results
  417. [417] Item 7, MD&A — Segment Results
  418. [418] Item 7, MD&A — Segment Results
  419. [419] Item 7, MD&A — Segment Results
  420. [420] Item 7, MD&A — Segment Results
  421. [421] Item 7, MD&A — Segment Results
  422. [422] Item 7, MD&A — Segment Results
  423. [423] Item 7, MD&A — Segment Results
  424. [424] Item 7, MD&A — Segment Results
  425. [425] Item 7, MD&A — Segment Results
  426. [426] Item 7, MD&A — Segment Results
  427. [427] Item 7, MD&A — Segment Results
  428. [428] Item 7, MD&A — Segment Results
  429. [429] Item 7, MD&A — Segment Results
  430. [430] Item 7, MD&A — Segment Results
  431. [431] Item 7, MD&A — Segment Results
  432. [432] Item 7, MD&A — Segment Results
  433. [433] Item 7, MD&A — Segment Results
  434. [434] Item 7, MD&A — Segment Results
  435. [435] Item 7, MD&A — Segment Results
  436. [436] Item 7, MD&A — Segment Results
  437. [437] Item 7, MD&A — Segment Results
  438. [438] Item 7, MD&A — Segment Results
  439. [439] Item 7, MD&A — Segment Results
  440. [440] Item 7, MD&A — Segment Results
  441. [441] Item 7, MD&A — Segment Results
  442. [442] Item 7, MD&A — Segment Results
  443. [443] Item 7, MD&A — Segment Results
  444. [444] Item 7, MD&A — Segment Results
  445. [445] Item 7, MD&A — Segment Results
  446. [446] Item 7, MD&A — Segment Results
  447. [447] Item 7, MD&A — Segment Results
  448. [448] Item 7, MD&A — Segment Results
  449. [449] Item 7, MD&A — Segment Results
  450. [450] Item 7, MD&A — Segment Results
  451. [451] Item 7, MD&A — Segment Results
  452. [452] Item 7, MD&A — Segment Results
  453. [453] Item 7, MD&A — Segment Results
  454. [454] Item 7, MD&A — Segment Results
  455. [455] Item 7, MD&A — Segment Results
  456. [456] Item 7, MD&A — Segment Results
  457. [457] Item 7, MD&A — Segment Results
  458. [458] Item 7, MD&A — Segment Results
  459. [459] Item 7, MD&A — Segment Results
  460. [460] Item 7, MD&A — Segment Results
  461. [461] Item 7, MD&A — Segment Results
  462. [462] Item 7, MD&A — Segment Results
  463. [463] Item 7, MD&A — Segment Results
  464. [464] Item 7, MD&A — Segment Results
  465. [465] Item 7, MD&A — Segment Results
  466. [466] Item 7, MD&A — Segment Results
  467. [467] Item 7, MD&A — Segment Results
  468. [468] Item 7, MD&A — Segment Results
  469. [469] Item 7, MD&A — Segment Results
  470. [470] Item 7, MD&A — Segment Results
  471. [471] Item 7, MD&A — Segment Results
  472. [472] Item 7, MD&A — Segment Results
  473. [473] Item 7, MD&A — Segment Results
  474. [474] Item 7, MD&A — Segment Results
  475. [475] Item 7, MD&A — Segment Results
  476. [476] Item 7, MD&A — Segment Results
  477. [477] Item 7, MD&A — Segment Results
  478. [478] Item 7, MD&A — Segment Results
  479. [479] Item 7, MD&A — Segment Results
  480. [480] Item 7, MD&A — Segment Results
  481. [481] Item 7, MD&A — Segment Results
  482. [482] Item 7, MD&A — Segment Results
  483. [483] Item 7, MD&A — Segment Results
  484. [484] Item 7, MD&A — Segment Results
  485. [485] Item 7, MD&A — Segment Results
  486. [486] Item 7, MD&A — Segment Results
  487. [487] Item 7, MD&A — Segment Results
  488. [488] Item 7, MD&A — Segment Results
  489. [489] Item 7, MD&A — Segment Results
  490. [490] Item 7, MD&A — Segment Results
  491. [491] Item 7, MD&A — Segment Results
  492. [492] Item 7, MD&A — Segment Results
  493. [493] Item 7, MD&A — Segment Results
  494. [494] Item 7, MD&A — Segment Results
  495. [495] Item 7, MD&A — Segment Results
  496. [496] Item 7, MD&A — Segment Results
  497. [497] Item 7, MD&A — Segment Results
  498. [498] Item 7, MD&A — Segment Results
  499. [499] Item 7, MD&A — Segment Results
  500. [500] Item 7, MD&A — Segment Results
  501. [501] Item 7, MD&A — Segment Results
  502. [502] Item 7, MD&A — Segment Results
  503. [503] Item 7, MD&A — Segment Results
  504. [504] Item 7, MD&A — Segment Results
  505. [505] Item 7, MD&A — Segment Results
  506. [506] Item 7, MD&A — Segment Results
  507. [507] Item 7, MD&A — Segment Results
  508. [508] Item 7, MD&A — Segment Results
  509. [509] Item 7, MD&A — Segment Results
  510. [510] Item 7, MD&A — Segment Results
  511. [511] Item 7, MD&A — Segment Results
  512. [512] Item 7, MD&A — Segment Results
  513. [513] Item 7, MD&A — Segment Results
  514. [514] Item 7, MD&A — Segment Results
  515. [515] Item 7, MD&A — Segment Results
  516. [516] Item 7, MD&A — Segment Results
  517. [517] Item 7, MD&A — Segment Results
  518. [518] Item 7, MD&A — Segment Results
  519. [519] Item 7, MD&A — Segment Results
  520. [520] Item 7, MD&A — Segment Results
  521. [521] Item 7, MD&A — Segment Results
  522. [522] Item 7, MD&A — Segment Results
  523. [523] Item 7, MD&A — Segment Results
  524. [524] Item 7, MD&A — Segment Results
  525. [525] Item 7, MD&A — Segment Results
  526. [526] Item 7, MD&A — Segment Results
  527. [527] Item 7, MD&A — Segment Results
  528. [528] Item 7, MD&A — Segment Results
  529. [529] Item 7, MD&A — Segment Results
  530. [530] Item 7, MD&A — Segment Results
  531. [531] Item 7, MD&A — Segment Results
  532. [532] Item 7, MD&A — Segment Results
  533. [533] Item 7, MD&A — Segment Results
  534. [534] Item 7, MD&A — Segment Results
  535. [535] Item 7, MD&A — Segment Results
  536. [536] Item 7, MD&A — Segment Results
  537. [537] Item 7, MD&A — Segment Results
  538. [538] Item 7, MD&A — Segment Results
  539. [539] Item 7, MD&A — Segment Results
  540. [540] Item 7, MD&A — Segment Results
  541. [541] Item 7, MD&A — Segment Results
  542. [542] Item 7, MD&A — Segment Results
  543. [543] Item 7, MD&A — Segment Results
  544. [544] Item 7, MD&A — Segment Results
  545. [545] Item 7, MD&A — Segment Results
  546. [546] Item 7, MD&A — Segment Results
  547. [547] Item 7, MD&A — Segment Results
  548. [548] Item 7, MD&A — Segment Results
  549. [549] Item 7, MD&A — Segment Results
  550. [550] Item 7, MD&A — Segment Results
  551. [551] Item 7, MD&A — Segment Results
  552. [552] Item 7, MD&A — Segment Results
  553. [553] Item 7, MD&A — Segment Results
  554. [554] Item 7, MD&A — Segment Results
  555. [555] Item 7, MD&A — Segment Results
  556. [556] Item 7, MD&A — Segment Results
  557. [557] Item 7, MD&A — Segment Results
  558. [558] Item 7, MD&A — Segment Results
  559. [559] Item 7, MD&A — Segment Results
  560. [560] Item 7, MD&A — Segment Results
  561. [561] Item 7, MD&A — Segment Results
  562. [562] Item 7, MD&A — Segment Results
  563. [563] Item 7, MD&A — Segment Results
  564. [564] Item 7, MD&A — Segment Results
  565. [565] Item 7, MD&A — Segment Results
  566. [566] Item 7, MD&A — Segment Results
  567. [567] Item 7, MD&A — Segment Results
  568. [568] Item 7, MD&A — Segment Results
  569. [569] Item 7, MD&A — Segment Results
  570. [570] Item 7, MD&A — Segment Results
  571. [571] Item 7, MD&A — Segment Results
  572. [572] Item 7, MD&A — Segment Results
  573. [573] Item 7, MD&A — Segment Results
  574. [574] Item 7, MD&A — Segment Results
  575. [575] Item 7, MD&A — Segment Results
  576. [576] Item 7, MD&A — Segment Results
  577. [577] Item 7, MD&A — Segment Results
  578. [578] Item 7, MD&A — Segment Results
  579. [579] Item 7, MD&A — Segment Results
  580. [580] Item 7, MD&A — Segment Results
  581. [581] Item 7, MD&A — Segment Results
  582. [582] Item 7, MD&A — Segment Results
  583. [583] Item 7, MD&A — Segment Results
  584. [584] Item 7, MD&A — Segment Results
  585. [585] Item 7, MD&A — Segment Results
  586. [586] Item 7, MD&A — Segment Results
  587. [587] Item 7, MD&A — Segment Results
  588. [588] Item 7, MD&A — Segment Results
  589. [589] Item 7, MD&A — Segment Results
  590. [590] Item 7, MD&A — Segment Results
  591. [591] Item 7, MD&A — Segment Results
  592. [592] Item 7, MD&A — Segment Results
  593. [593] Item 7, MD&A — Segment Results
  594. [594] Item 7, MD&A — Segment Results
  595. [595] Item 7, MD&A — Segment Results
  596. [596] Item 7, MD&A — Segment Results
  597. [597] Item 7, MD&A — Segment Results
  598. [598] Item 7, MD&A — Segment Results
  599. [599] Item 7, MD&A — Segment Results
  600. [600] Item 7, MD&A — Segment Results
  601. [601] Item 7, MD&A — Segment Results
  602. [602] Item 7, MD&A — Segment Results
  603. [603] Item 7, MD&A — Segment Results
  604. [604] Item 7, MD&A — Segment Results
  605. [605] Item 7, MD&A — Segment Results
  606. [606] Item 7, MD&A — Segment Results
  607. [607] Item 7, MD&A — Segment Results
  608. [608] Item 7, MD&A — Segment Results
  609. [609] Item 7, MD&A — Segment Results
  610. [610] Item 7, MD&A — Segment Results
  611. [611] Item 7, MD&A — Segment Results
  612. [612] Item 7, MD&A — Segment Results
  613. [613] Item 7, MD&A — Segment Results
  614. [614] Item 7, MD&A — Segment Results
  615. [615] Item 7, MD&A — Segment Results
  616. [616] Item 7, MD&A — Segment Results
  617. [617] Item 7, MD&A — Segment Results
  618. [618] Item 7, MD&A — Segment Results
  619. [619] Item 7, MD&A — Segment Results
  620. [620] Item 7, MD&A — Segment Results
  621. [621] Item 7, MD&A — Segment Results
  622. [622] Item 7, MD&A — Segment Results
  623. [623] Item 7, MD&A — Segment Results
  624. [624] Item 7, MD&A — Segment Results
  625. [625] Item 7, MD&A — Segment Results
  626. [626] Item 7, MD&A — Segment Results
  627. [627] Item 7, MD&A — Segment Results
  628. [628] Item 7, MD&A — Segment Results
  629. [629] Item 7, MD&A — Segment Results
  630. [630] Item 7, MD&A — Segment Results
  631. [631] Item 7, MD&A — Segment Results
  632. [632] Item 7, MD&A — Segment Results
  633. [633] Item 7, MD&A — Segment Results
  634. [634] Item 7, MD&A — Segment Results
  635. [635] Item 7, MD&A — Segment Results
  636. [636] Item 7, MD&A — Segment Results
  637. [637] Item 7, MD&A — Segment Results
  638. [638] Item 7, MD&A — Segment Results
  639. [639] Item 7, MD&A — Segment Results
  640. [640] Item 7, MD&A — Segment Results
  641. [641] Item 7, MD&A — Segment Results
  642. [642] Item 7, MD&A — Segment Results
  643. [643] Item 7, MD&A — Segment Results
  644. [644] Item 7, MD&A — Segment Results
  645. [645] Item 7, MD&A — Segment Results
  646. [646] Item 7, MD&A — Segment Results
  647. [647] Item 7, MD&A — Segment Results
  648. [648] Item 7, MD&A — Segment Results
  649. [649] Item 7, MD&A — Segment Results
  650. [650] Item 7, MD&A — Segment Results
  651. [651] Item 7, MD&A — Segment Results
  652. [652] Item 7, MD&A — Segment Results
  653. [653] Item 7, MD&A — Segment Results
  654. [654] Item 7, MD&A — Segment Results
  655. [655] Item 7, MD&A — Segment Results
  656. [656] Item 7, MD&A — Segment Results
  657. [657] Item 7, MD&A — Segment Results
  658. [658] Item 7, MD&A — Segment Results
  659. [659] Item 7, MD&A — Segment Results
  660. [660] Item 7, MD&A — Segment Results
  661. [661] Item 7, MD&A — Segment Results
  662. [662] Item 7, MD&A — Segment Results
  663. [663] Item 7, MD&A — Segment Results
  664. [664] Item 7, MD&A — Segment Results
  665. [665] Item 7, MD&A — Segment Results
  666. [666] Item 7, MD&A — Segment Results
  667. [667] Item 7, MD&A — Segment Results
  668. [668] Item 7, MD&A — Segment Results
  669. [669] Item 7, MD&A — Segment Results
  670. [670] Item 7, MD&A — Segment Results
  671. [671] Item 7, MD&A — Segment Results
  672. [672] Item 7, MD&A — Segment Results
  673. [673] Item 7, MD&A — Segment Results
  674. [674] Item 7, MD&A — Segment Results
  675. [675] Item 7, MD&A — Segment Results
  676. [676] Item 7, MD&A — Segment Results
  677. [677] Item 7, MD&A — Segment Results
  678. [678] Item 7, MD&A — Segment Results
  679. [679] Item 7, MD&A — Segment Results
  680. [680] Item 7, MD&A — Segment Results
  681. [681] Item 7, MD&A — Segment Results
  682. [682] Item 7, MD&A — Segment Results
  683. [683] Item 7, MD&A — Segment Results
  684. [684] Item 7, MD&A — Segment Results
  685. [685] Item 7, MD&A — Segment Results
  686. [686] Item 7, MD&A — Segment Results
  687. [687] Item 7, MD&A — Segment Results
  688. [688] Item 7, MD&A — Segment Results
  689. [689] Item 7, MD&A — Segment Results
  690. [690] Item 7, MD&A — Segment Results
  691. [691] Item 7, MD&A — Segment Results
  692. [692] Item 7, MD&A — Segment Results
  693. [693] Item 7, MD&A — Segment Results
  694. [694] Item 7, MD&A — Segment Results
  695. [695] Item 7, MD&A — Segment Results
  696. [696] Item 7, MD&A — Segment Results
  697. [697] Item 7, MD&A — Segment Results
  698. [698] Item 7, MD&A — Segment Results
  699. [699] Item 7, MD&A — Segment Results
  700. [700] Item 7, MD&A — Segment Results
  701. [701] Item 7, MD&A — Segment Results
  702. [702] Item 7, MD&A — Segment Results
  703. [703] Item 7, MD&A — Segment Results
  704. [704] Item 7, MD&A — Segment Results
  705. [705] Item 7, MD&A — Segment Results
  706. [706] Item 7, MD&A — Segment Results
  707. [707] Item 7, MD&A — Segment Results
  708. [708] Item 7, MD&A — Segment Results
  709. [709] Item 7, MD&A — Segment Results
  710. [710] Item 7, MD&A — Segment Results
  711. [711] Item 7, MD&A — Segment Results
  712. [712] Item 7, MD&A — Segment Results
  713. [713] Item 7, MD&A — Segment Results
  714. [714] Item 7, MD&A — Segment Results
  715. [715] Item 7, MD&A — Segment Results
  716. [716] Item 7, MD&A — Segment Results
  717. [717] Item 7, MD&A — Segment Results
  718. [718] Item 7, MD&A — Segment Results
  719. [719] Item 7, MD&A — Segment Results
  720. [720] Item 7, MD&A — Segment Results
  721. [721] Item 7, MD&A — Segment Results
  722. [722] Item 7, MD&A — Segment Results
  723. [723] Item 7, MD&A — Segment Results
  724. [724] Item 7, MD&A — Segment Results
  725. [725] Item 7, MD&A — Segment Results
  726. [726] Item 7, MD&A — Segment Results
  727. [727] Item 7, MD&A — Segment Results
  728. [728] Item 7, MD&A — Segment Results
  729. [729] Item 7, MD&A — Segment Results
  730. [730] Item 7, MD&A — Segment Results
  731. [731] Item 7, MD&A — Segment Results
  732. [732] Item 7, MD&A — Segment Results
  733. [733] Item 7, MD&A — Segment Results
  734. [734] Item 7, MD&A — Segment Results
  735. [735] Item 7, MD&A — Segment Results
  736. [736] Item 7, MD&A — Segment Results
  737. [737] Item 7, MD&A — Segment Results
  738. [738] Item 7, MD&A — Segment Results
  739. [739] Item 7, MD&A — Segment Results
  740. [740] Item 7, MD&A — Segment Results
  741. [741] Item 7, MD&A — Segment Results
  742. [742] Item 7, MD&A — Segment Results
  743. [743] Item 7, MD&A — Segment Results
  744. [744] Item 7, MD&A — Segment Results
  745. [745] Item 7, MD&A — Segment Results
  746. [746] Item 7, MD&A — Segment Results
  747. [747] Item 7, MD&A — Segment Results
  748. [748] Item 7, MD&A — Segment Results
  749. [749] Item 7, MD&A — Segment Results
  750. [750] Item 7, MD&A — Segment Results
  751. [751] Item 7, MD&A — Segment Results
  752. [752] Item 7, MD&A — Segment Results
  753. [753] Item 7, MD&A — Segment Results
  754. [754] Item 7, MD&A — Segment Results
  755. [755] Item 7, MD&A — Segment Results
  756. [756] Item 7, MD&A — Segment Results
  757. [757] Item 7, MD&A — Segment Results
  758. [758] Item 7, MD&A — Segment Results
  759. [759] Item 7, MD&A — Segment Results
  760. [760] Item 7, MD&A — Segment Results
  761. [761] Item 7, MD&A — Segment Results
  762. [762] Item 7, MD&A — Segment Results
  763. [763] Item 7, MD&A — Segment Results
  764. [764] Item 7, MD&A — Segment Results
  765. [765] Item 7, MD&A — Segment Results
  766. [766] Item 7, MD&A — Segment Results
  767. [767] Item 7, MD&A — Segment Results
  768. [768] Item 7, MD&A — Segment Results
  769. [769] Item 7, MD&A — Segment Results
  770. [770] Item 7, MD&A — Segment Results
  771. [771] Item 7, MD&A — Segment Results
  772. [772] Item 7, MD&A — Segment Results
  773. [773] Item 7, MD&A — Segment Results
  774. [774] Item 7, MD&A — Segment Results
  775. [775] Item 7, MD&A — Segment Results
  776. [776] Item 7, MD&A — Segment Results
  777. [777] Item 7, MD&A — Segment Results
  778. [778] Item 7, MD&A — Segment Results
  779. [779] Item 7, MD&A — Segment Results
  780. [780] Item 7, MD&A — Segment Results
  781. [781] Item 7, MD&A — Segment Results
  782. [782] Item 7, MD&A — Segment Results
  783. [783] Item 7, MD&A — Segment Results
  784. [784] Item 7, MD&A — Segment Results
  785. [785] Item 7, MD&A — Segment Results
  786. [786] Item 7, MD&A — Segment Results
  787. [787] Item 7, MD&A — Segment Results
  788. [788] Item 7, MD&A — Segment Results
  789. [789] Item 7, MD&A — Segment Results
  790. [790] Item 7, MD&A — Segment Results
  791. [791] Item 7, MD&A — Segment Results
  792. [792] Item 7, MD&A — Segment Results
  793. [793] Item 7, MD&A — Segment Results
  794. [794] Item 7, MD&A — Segment Results
  795. [795] Item 7, MD&A — Segment Results
  796. [796] Item 7, MD&A — Segment Results
  797. [797] Item 7, MD&A — Segment Results
  798. [798] Item 7, MD&A — Segment Results
  799. [799] Item 7, MD&A — Segment Results
  800. [800] Item 7, MD&A — Segment Results
  801. [801] Item 7, MD&A — Segment Results
  802. [802] Item 7, MD&A — Segment Results
  803. [803] Item 7, MD&A — Segment Results
  804. [804] Item 7, MD&A — Segment Results
  805. [805] Item 7, MD&A — Segment Results
  806. [806] Item 7, MD&A — Segment Results
  807. [807] Item 7, MD&A — Segment Results
  808. [808] Item 7, MD&A — Segment Results
  809. [809] Item 7, MD&A — Segment Results
  810. [810] Item 7, MD&A — Segment Results
  811. [811] Item 7, MD&A — Segment Results
  812. [812] Item 7, MD&A — Segment Results
  813. [813] Item 7, MD&A — Segment Results
  814. [814] Item 7, MD&A — Segment Results
  815. [815] Item 7, MD&A — Segment Results
  816. [816] Item 7, MD&A — Segment Results
  817. [817] Item 7, MD&A — Segment Results
  818. [818] Item 7, MD&A — Segment Results
  819. [819] Item 7, MD&A — Segment Results
  820. [820] Item 7, MD&A — Segment Results
  821. [821] Item 7, MD&A — Segment Results
  822. [822] Item 7, MD&A — Segment Results
  823. [823] Item 7, MD&A — Segment Results
  824. [824] Item 7, MD&A — Segment Results
  825. [825] Item 7, MD&A — Segment Results
  826. [826] Item 7, MD&A — Segment Results
  827. [827] Item 7, MD&A — Segment Results
  828. [828] Item 7, MD&A — Segment Results
  829. [829] Item 7, MD&A — Segment Results
  830. [830] Item 7, MD&A — Segment Results
  831. [831] Item 7, MD&A — Segment Results
  832. [832] Item 7, MD&A — Segment Results
  833. [833] Item 7, MD&A — Segment Results
  834. [834] Item 7, MD&A — Segment Results
  835. [835] Item 7, MD&A — Segment Results
  836. [836] Item 7, MD&A — Segment Results
  837. [837] Item 7, MD&A — Segment Results
  838. [838] Item 7, MD&A — Segment Results
  839. [839] Item 7, MD&A — Segment Results
  840. [840] Item 7, MD&A — Segment Results
  841. [841] Item 7, MD&A — Segment Results
  842. [842] Item 7, MD&A — Segment Results
  843. [843] Item 7, MD&A — Segment Results
  844. [844] Item 7, MD&A — Segment Results
  845. [845] Item 7, MD&A — Segment Results
  846. [846] Item 7, MD&A — Segment Results
  847. [847] Item 7, MD&A — Segment Results
  848. [848] Item 7, MD&A — Segment Results
  849. [849] Item 7, MD&A — Segment Results
  850. [850] Item 7, MD&A — Segment Results
  851. [851] Item 7, MD&A — Segment Results
  852. [852] Item 7, MD&A — Segment Results
  853. [853] Item 7, MD&A — Segment Results
  854. [854] Item 7, MD&A — Segment Results
  855. [855] Item 7, MD&A — Segment Results
  856. [856] Item 7, MD&A — Segment Results
  857. [857] Item 7, MD&A — Segment Results
  858. [858] Item 7, MD&A — Segment Results
  859. [859] Item 7, MD&A — Segment Results
  860. [860] Item 7, MD&A — Segment Results
  861. [861] Item 7, MD&A — Segment Results
  862. [862] Item 7, MD&A — Segment Results
  863. [863] Item 7, MD&A — Segment Results
  864. [864] Item 7, MD&A — Segment Results
  865. [865] Item 7, MD&A — Segment Results
  866. [866] Item 7, MD&A — Segment Results
  867. [867] Item 7, MD&A — Segment Results
  868. [868] Item 7, MD&A — Segment Results
  869. [869] Item 7, MD&A — Segment Results
  870. [870] Item 7, MD&A — Segment Results
  871. [871] Item 7, MD&A — Segment Results
  872. [872] Item 7, MD&A — Segment Results
  873. [873] Item 7, MD&A — Segment Results
  874. [874] Item 7, MD&A — Segment Results
  875. [875] Item 7, MD&A — Segment Results
  876. [876] Item 7, MD&A — Segment Results
  877. [877] Item 7, MD&A — Segment Results
  878. [878] Item 7, MD&A — Segment Results
  879. [879] Item 7, MD&A — Segment Results
  880. [880] Item 7, MD&A — Segment Results
  881. [881] Item 7, MD&A — Segment Results
  882. [882] Item 7, MD&A — Segment Results
  883. [883] Item 7, MD&A — Segment Results
  884. [884] Item 7, MD&A — Segment Results
  885. [885] Item 7, MD&A — Segment Results
  886. [886] Item 7, MD&A — Segment Results
  887. [887] Item 7, MD&A — Segment Results
  888. [888] Item 7, MD&A — Segment Results
  889. [889] Item 7, MD&A — Segment Results
  890. [890] Item 7, MD&A — Segment Results
  891. [891] Item 7, MD&A — Segment Results
  892. [892] Item 7, MD&A — Segment Results
  893. [893] Item 7, MD&A — Segment Results
  894. [894] Item 7, MD&A — Segment Results
  895. [895] Item 7, MD&A — Segment Results
  896. [896] Item 7, MD&A — Segment Results
  897. [897] Item 7, MD&A — Segment Results
  898. [898] Item 7, MD&A — Segment Results
  899. [899] Item 7, MD&A — Segment Results
  900. [900] Item 7, MD&A — Segment Results
  901. [901] Item 7, MD&A — Segment Results
  902. [902] Item 7, MD&A — Segment Results
  903. [903] Item 7, MD&A — Segment Results
  904. [904] Item 7, MD&A — Segment Results
  905. [905] Item 7, MD&A — Segment Results
  906. [906] Item 7, MD&A — Segment Results
  907. [907] Item 7, MD&A — Segment Results
  908. [908] Item 7, MD&A — Segment Results
  909. [909] Item 7, MD&A — Segment Results
  910. [910] Item 7, MD&A — Segment Results
  911. [911] Item 7, MD&A — Segment Results
  912. [912] Item 7, MD&A — Segment Results
  913. [913] Item 7, MD&A — Segment Results
  914. [914] Item 7, MD&A — Segment Results
  915. [915] Item 7, MD&A — Segment Results
  916. [916] Item 7, MD&A — Segment Results
  917. [917] Item 7, MD&A — Segment Results
  918. [918] Item 7, MD&A — Segment Results
  919. [919] Item 7, MD&A — Segment Results
  920. [920] Item 7, MD&A — Segment Results
  921. [921] Item 7, MD&A — Segment Results
  922. [922] Item 7, MD&A — Segment Results
  923. [923] Item 7, MD&A — Segment Results
  924. [924] Item 7, MD&A — Segment Results
  925. [925] Item 7, MD&A — Segment Results
  926. [926] Item 7, MD&A — Segment Results
  927. [927] Item 7, MD&A — Segment Results
  928. [928] Item 7, MD&A — Segment Results
  929. [929] Item 7, MD&A — Segment Results
  930. [930] Item 7, MD&A — Segment Results
  931. [931] Item 7, MD&A — Segment Results
  932. [932] Item 7, MD&A — Segment Results
  933. [933] Item 7, MD&A — Segment Results
  934. [934] Item 7, MD&A — Segment Results
  935. [935] Item 7, MD&A — Segment Results
  936. [936] Item 7, MD&A — Segment Results
  937. [937] Item 7, MD&A — Segment Results
  938. [938] Item 7, MD&A — Segment Results
  939. [939] Item 7, MD&A — Segment Results
  940. [940] Item 7, MD&A — Segment Results
  941. [941] Item 7, MD&A — Segment Results
  942. [942] Item 7, MD&A — Segment Results
  943. [943] Item 7, MD&A — Segment Results
  944. [944] Item 7, MD&A — Segment Results
  945. [945] Item 7, MD&A — Segment Results
  946. [946] Item 7, MD&A — Segment Results
  947. [947] Item 7, MD&A — Segment Results
  948. [948] Item 7, MD&A — Segment Results
  949. [949] Item 7, MD&A — Segment Results
  950. [950] Item 7, MD&A — Segment Results
  951. [951] Item 7, MD&A — Segment Results
  952. [952] Item 7, MD&A — Segment Results
  953. [953] Item 7, MD&A — Segment Results
  954. [954] Item 7, MD&A — Segment Results
  955. [955] Item 7, MD&A — Segment Results
  956. [956] Item 7, MD&A — Segment Results
  957. [957] Item 7, MD&A — Segment Results
  958. [958] Item 7, MD&A — Segment Results
  959. [959] Item 7, MD&A — Segment Results
  960. [960] Item 7, MD&A — Segment Results
  961. [961] Item 7, MD&A — Segment Results
  962. [962] Item 7, MD&A — Segment Results
  963. [963] Item 7, MD&A — Segment Results
  964. [964] Item 7, MD&A — Segment Results
  965. [965] Item 7, MD&A — Segment Results
  966. [966] Item 7, MD&A — Segment Results
  967. [967] Item 7, MD&A — Segment Results
  968. [968] Item 7, MD&A — Segment Results
  969. [969] Item 7, MD&A — Segment Results
  970. [970] Item 7, MD&A — Segment Results
  971. [971] Item 7, MD&A — Segment Results
  972. [972] Item 7, MD&A — Segment Results
  973. [973] Item 7, MD&A — Segment Results
  974. [974] Item 7, MD&A — Segment Results
  975. [975] Item 7, MD&A — Segment Results
  976. [976] Item 7, MD&A — Segment Results
  977. [977] Item 7, MD&A — Segment Results
  978. [978] Item 7, MD&A — Segment Results
  979. [979] Item 7, MD&A — Segment Results
  980. [980] Item 7, MD&A — Segment Results
  981. [981] Item 7, MD&A — Segment Results
  982. [982] Item 7, MD&A — Segment Results
  983. [983] Item 7, MD&A — Segment Results
  984. [984] Item 7, MD&A — Segment Results
  985. [985] Item 7, MD&A — Segment Results
  986. [986] Item 7, MD&A — Segment Results
  987. [987] Item 7, MD&A — Segment Results
  988. [988] Item 7, MD&A — Segment Results
  989. [989] Item 7, MD&A — Segment Results
  990. [990] Item 7, MD&A — Segment Results
  991. [991] Item 7, MD&A — Segment Results
  992. [992] Item 7, MD&A — Segment Results
  993. [993] Item 7, MD&A — Segment Results
  994. [994] Item 7, MD&A — Segment Results
  995. [995] Item 7, MD&A — Segment Results
  996. [996] Item 7, MD&A — Segment Results
  997. [997] Item 7, MD&A — Segment Results
  998. [998] Item 7, MD&A — Segment Results
  999. [999] Item 7, MD&A — Segment Results
  1000. [1000] Item 7, MD&A — Segment Results

Analysis on 11/2/2026